• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » HealthiVibe, Elite Research Network partner on clinical trial participant experience surveys

HealthiVibe, Elite Research Network partner on clinical trial participant experience surveys

December 9, 2016
CenterWatch Staff

HealthiVibe has partnered with Elite Research Network in an effort to improve the clinical trial experience and gather industry benchmarking data by offering the HealthiPerspectives clinical trial participant experience surveys to patients via sites within Elite Research Network.

In 2015, HealthiVibe released HealthiPerspectives to capture clinical trial participant feedback at various time points throughout the clinical trial experience—enrollment, mid-point and close-out. Surveys have already been fielded on behalf of global pharmaceutical companies in 11 countries, with survey findings providing substantive qualitative feedback to assist trial sponsors and investigators in the shift to more patient-centric study design and execution.

The surveys will be provided to Elite Research Network sites via touchscreen tablets for a variety of clinical trials across multiple therapeutic areas including neurology, gastroenterology, vaccines, endocrinology, musculoskeletal, and more.

Jennifer Kelly, senior director, Operations at HealthiVibe, noted that this partnership marks a significant expansion of the offering. “This will allow us to gather feedback and actionable insights from a broader base of patients identified directly from the sites, focusing on the issues that matter most to patients, from travel logistics to site communication,” she said. Leveraging Elite Research Network’s large number of active studies, she said, “will also help to build out HealthiVibe’s industry benchmarking database, providing valuable context that will ultimately be of benefit to everyone in our industry who shares our mission of making the patient voice paramount to the clinical trial development process.”

“Our sites understand the power of the patient voice in clinical trials so we are very excited to partner with HealthiVibe on this important initiative,” said Rachael MacQueen, site liaison for Elite Research Network. “With the patient feedback gathered through the HealthiPerspectives survey—both positive and constructive—we will be able to work with our investigators and trial sponsors to make real-time adjustments to study protocols resulting in faster, more effective, and less expensive research and development that caters to the study participant’s needs.”

Built on the premise that the patient voice is critical to all phases of the pharmaceutical product lifecycle, HealthiVibe offers a systematic, structured process for sponsors and sites to engage with patients at every stage: from clinical trial design all the way through post-approval activities and research. Offering a full-service solution that spans a range of activities, from moderating patient advisory boards to fielding clinical trial participant surveys to performing qualitative and quantitative outcomes research, HealthiVibe works to help our clients continuously engage with patients, improve clinical trial design, and bring all aspects of the product lifecycle into alignment with patient needs. HealthiVibe will be adding more site networks in the second quarter of 2017.

Founded in 2004, Elite Research Network is a group of 27 top performing investigative sites located across the U.S. with a wide variety of therapeutic experience. With over 175 investigators, the network conducts more than 400 studies each year. Operating under a unique business model, they offer efficiencies through centralized business development, contract and budget negotiations, and patient recruitment. The group is known for accelerated study start-up, rapid enrollment and dedication to the highest quality standards leading them to be a preferred partner to many pharmaceutical companies and CRO’s.

Upcoming Events

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

  • VaccinewithNeedle-360x240.png

    2021 Vaccine Industry Will Continue to be Dominated by COVID-19 Trials, Experts Say

  • Dominate-360x240.png

    COVID-19, Oncology, CNS and Infectious Disease Trials Will Dominate in 2021, Survey Predicts

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing